Alpha Teknova's (TKNO) "Sell (D-)" Rating Reaffirmed at Weiss Ratings

Key Points

• Weiss Ratings has reaffirmed a "sell (D-)" rating for Alpha Teknova (NASDAQ:TKNO), indicating a negative outlook from these analysts.
• Despite the negative rating from Weiss, Stephens upgraded the stock to "strong-buy" with a target price of $8.00.
• Alpha Teknova reported earnings of ($0.07) per share, beating expectations, with revenue of $10.29 million against estimated $9.90 million.

Alpha Teknova (NASDAQ:TKNO - Get Free Report)'s stock had its "sell (d-)" rating restated by equities researchers at Weiss Ratings in a research report issued on Friday,Weiss Ratings reports.

Separately, Stephens raised Alpha Teknova to a "strong-buy" rating and set a $8.00 target price on the stock in a research note on Tuesday, July 22nd. One analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating and one has assigned a Sell rating to the company's stock. According to data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average price target of $10.00.

Alpha Teknova Trading Down 0.9%

NASDAQ TKNO traded down $0.05 on Friday, hitting $5.71. 94,515 shares of the company were exchanged, compared to its average volume of 343,246. The company has a debt-to-equity ratio of 0.17, a current ratio of 5.87 and a quick ratio of 4.70. Alpha Teknova has a twelve month low of $3.94 and a twelve month high of $10.37. The company's 50 day moving average price is $4.96 and its 200-day moving average price is $5.32. The firm has a market capitalization of $305.54 million, a P/E ratio of -13.61 and a beta of 0.41.

Alpha Teknova (NASDAQ:TKNO - Get Free Report) last released its earnings results on Thursday, August 7th. The company reported ($0.07) earnings per share for the quarter, beating the consensus estimate of ($0.10) by $0.03. Alpha Teknova had a negative return on equity of 26.51% and a negative net margin of 55.24%.The company had revenue of $10.29 million for the quarter, compared to analysts' expectations of $9.90 million. Alpha Teknova has set its FY 2025 guidance at EPS. Analysts predict that Alpha Teknova will post -0.58 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Alpha Teknova

Several large investors have recently made changes to their positions in TKNO. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. bought a new stake in shares of Alpha Teknova in the 2nd quarter valued at approximately $29,000. Larson Financial Group LLC acquired a new position in shares of Alpha Teknova during the first quarter worth approximately $30,000. JPMorgan Chase & Co. lifted its holdings in shares of Alpha Teknova by 123.1% during the second quarter. JPMorgan Chase & Co. now owns 8,163 shares of the company's stock worth $40,000 after buying an additional 4,504 shares during the last quarter. Stratos Wealth Advisors LLC acquired a new position in shares of Alpha Teknova during the first quarter worth approximately $59,000. Finally, McAdam LLC acquired a new position in shares of Alpha Teknova during the first quarter worth approximately $60,000. Institutional investors own 13.81% of the company's stock.

About Alpha Teknova

Alpha Teknova, Inc produces critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.